Avaliação do perfil de pacientes usuários crônicos de inibidores da bomba de prótons
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Avaliar o perfil dos pacientes usuários crônicos e investigar os impactos negativos a curto, médio e longo prazo na saúde de usuários crônicos de inibidores da bomba de prótons (IBPs). Métodos: A coleta de dados foi transversal, descritiva e observacional, com abordagem qualitativa e quantitativa. Esta é uma revisão bibliográfica exploratória e descritiva, realizada de maneira organizada, sistemática e ética, com dados já existentes das bases de dados PubMed e UpToDate. Resultados: O N coletado foi de 31 pacientes usuários de IBP, sendo 21 mulheres e 10 homens, com tempo de uso do IBP variando de 67 dias a 15 anos. Os resultados foram apresentados por meio de gráficos, alguns corroborando estudos pré-existentes e outros mostrando divergências com a literatura médica. Conclusão: Mais estudos devem ser realizados a fim de se estabelecer uma relação causal dos efeitos a longo prazo do uso dos inibidores da bomba de prótons no organismo humano.
##plugins.themes.bootstrap3.article.details##
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
2. AUERBACH M, et al. Causes and diagnosis of iron deficiency and iron deficiency anemia in adults. Up to Date. 2022.
3. AUSTIN G. Association of Proton Pump Inhibitor Use with Serum Biomarkers of Inflammation, Insulin Resistance, Cardiovascular Risk, and Renal Function. Journal of Clinical Gastroenterology, 2018; 52(8): 691-695.
4. CORLETO VD, et al. Proton pump inhibitor therapy and potential long-term harm. Current opinion in endocrinology, diabetes, and obesity, 2014; 21(1): 3-8.
5. GIFFORD AH. et al. Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis. Pediatric Pulmonology, 2021; 56(7): 2048-2056.
6. GRAHAM D, TANSEL A. Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency. Clinical Gastroenterology and Hepatology, 2018; 16(6): 800-808.
7. HAASTRUP P, et al. When does proton pump inhibitor treatment become long term? A scoping review. BMJ Open Gastroenterology, 2021; 8(1).
8. JAYNES M, KUMAR A. The risks of long-term use of proton pump inhibitors: a critical review. Therapeutic advances in drug safety, 2018;10.
9. KAHRILAS P. Medical management of gastroesophageal reflux disease in adults. Up To Date, [s. l.], 2022.
10. KOYYADA A. Long term use of proton pump inhibitors as a risk factor for various adverse manifestations, 2021; 76(1): 13-21.
11. LAMONT T, Treatment regimens for Helicobacter pylori in adults. Up to Date, 2022.
12. LAZZERINI PE, et al. Proton Pump Inhibitors and Serum Magnesium Levels in Patients with Torsades de Pointes. Frontiers in pharmacology. 2018; 9: 363.
13. LEE L, et al. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome. International Journal of Molecular Sciences, 2019; 20(20): 5128.
14. LEE L, et al. Overview of colonoscopy in adults. UpToDate. Waltham, MA: UpToDate, 2021.
15. LI Z, et al. Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: A meta-analysis. Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association, 2017;
23(4): 222-228.
16. MOUSA H, HASSAN M. Gastroesophageal Reflux Disease. Pediatric Clinics of North America, 2017; 64(3): 487-505.
17. QORRAJ-BYTYQI, H et al. Proton Pump Inhibitors Intake and Iron and Vitamin B12 Status: A Prospective Comparative Study with a Follow up of 12 Months. Open access Macedonian journal of medical Sciences, 2018; 6(3): 442-446
18. VELAZQUEZ-DOHORN M, et al. Análisis de casos y controles de pólipos de glándulas fúndicas e inhibidores de bomba de protones. La perspectiva de un patólogo. Revista de Gastroenterología de México, 2020; 85(1): 42-47.
19. WANG Y et al. Association Between Proton Pump Inhibitor Use and Risk of Asthma in Children. JAMA pediatrics, 2021; 175(4): 394-403.
20. WOLFE M, et al. proton pump inhibitors: Overview of use and adverse effects in the treatment of acid related disorders. Up to Date, 2022.
21. YU A, et al. Hypomagnesemia: Causes of hypomagnesemia. Up to Date, 2022.
22. YU LY, et al. A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors. Advances in Therapy, 2017;34(5):1070-1086.
23. YU Z, et al. Neutropenia and Thrombocytopenia Induced by Proton Pump Inhibitors: A Case Report. 2018;5(1):28.
24. YU A, et al. Hypomagnesemia: Clinical manifestations of magnesium depletion. Up to date, 2022.
25. THOMSON A, et al. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol. 2010.